Reno-Protective Effects of SGLT2 Inhibitors in Patients With Diabetes Undergoing Percutaneous Coronary Intervention: Insights From the BMC2 Registry
Among patients with diabetes who underwent PCI, preprocedural use of SGLT2i correlated with a lower risk of CA-AKI.
Authors
- Michael R. Rudnick
- Milan Seth (ORCID: https://orcid.org/0000-0002-3472-1872)
- Devraj Sukul (ORCID: https://orcid.org/0000-0003-4709-3390)
- Edouard Daher
- Bashar Samman
- Carlo Briguori (ORCID: https://orcid.org/0000-0002-2105-8186)
- Heidi Stoute
- David Kojo Hamilton (ORCID: https://orcid.org/0009-0009-7713-7252)
- Vishal Gupta
- Joseph Chattahi
- S. Nabeel Hyder
- Hitinder S. Gurm
Institutions
- Van Andel Institute (US)
- University of Michigan (US)
- Beaumont Health (US)
- McLaren Health Care (US)
- Henry Ford Hospital (US)
- Clinica Mediterranea (IT)
- Borgess Medical Center (US)
- Beaumont Hospital (US)
- Kalamazoo College (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Circulation Cardiovascular Interventions
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1161/circinterventions.125.015645
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00